SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-15-010031
Filing Date
2015-05-14
Accepted
2015-05-14 08:05:07
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20150331_10q.htm 10-Q 919492
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 10878
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 10483
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5128
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 4872
  Complete submission text file 0001437749-15-010031.txt   6730497

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS nby-20150331.xml EX-101.INS 951143
7 EXHIBIT 101.SCH nby-20150331.xsd EX-101.SCH 54183
8 EXHIBIT 101.CAL nby-20150331_cal.xml EX-101.CAL 32124
9 EXHIBIT 101.DEF nby-20150331_def.xml EX-101.DEF 259897
10 EXHIBIT 101.LAB nby-20150331_lab.xml EX-101.LAB 374753
11 EXHIBIT 101.PRE nby-20150331_pre.xml EX-101.PRE 259861
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 15860309
SIC: 2834 Pharmaceutical Preparations